DrugPatentWatch Database Preview
Celgene Intl Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for CELGENE INTL, and when can generic versions of CELGENE INTL drugs launch?
CELGENE INTL has one approved drug.
There are three US patents protecting CELGENE INTL drugs.
There are twenty-three patent family members on CELGENE INTL drugs in twenty countries.
Summary for Celgene Intl
| International Patents: | 23 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Celgene Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Celgene Intl | ZEPOSIA | ozanimod hydrochloride | CAPSULE;ORAL | 209899-002 | Mar 25, 2020 | RX | Yes | No | Start Trial | Start Trial | |||||
| Celgene Intl | ZEPOSIA | ozanimod hydrochloride | CAPSULE;ORAL | 209899-002 | Mar 25, 2020 | RX | Yes | No | 8,796,318 | Start Trial | Y | Y | Start Trial | ||
| Celgene Intl | ZEPOSIA | ozanimod hydrochloride | CAPSULE;ORAL | 209899-001 | Mar 25, 2020 | RX | Yes | No | 8,481,573 | Start Trial | Y | Y | Start Trial | ||
| Celgene Intl | ZEPOSIA | ozanimod hydrochloride | CAPSULE;ORAL | 209899-001 | Mar 25, 2020 | RX | Yes | No | 8,796,318 | Start Trial | Y | Y | Start Trial | ||
| Celgene Intl | ZEPOSIA | ozanimod hydrochloride | CAPSULE;ORAL | 209899-002 | Mar 25, 2020 | RX | Yes | No | 8,481,573 | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Celgene Intl Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hungary | E025984 | Start Trial |
| China | 102118972 | Start Trial |
| Australia | 2009258242 | Start Trial |
| Australia | 2015213309 | Start Trial |
| Malaysia | 156381 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
